We are pleased to announce that we have received a grant from the Recovery and Resilience plan of 3 million EUR. It is intended for the development of diagnostic tests

Prostate cancer represents growing burden on healthcare systems – direct costs related to its treatment and diagnostics in Slovakia grew by more than 2.5 times from 20 mil EUR in

We have accepted an invitation from Slovak television TA3 to discuss prostate cancer, which is one of the most common oncological diseases among men in Slovakia. Dr. Boris Kollarik, key

We are very pleased that Innovate Slovakia has included us to the list of the most promising and innovative startups to watch in 2024. Success stories – Innovate Slovakia